Blastocystosis in Italy

Remission of chronic blastocystosis using ciprofloxacin

Blastocystis hominis is a controversial parasite because of its taxonomy and its treatment. In this report, an immunocompetent person with chronic blastocystosis, in whom a series of treatments were used without success, except for the use of ciprofloxaci. Ciprofloxacin could be an antibiotic of choice in chronic blastocystosis.

[Prevalence of Blastocystis hominis among food handlers from Caroni municipality, Bolivar State, Venezuela]

A cross-sectional survey was conducted to determine the prevalence of Blastocystis hominis infection in a random sample of apparently healthy food handlers. A total of 415 individuals attending the Manoa Urban Outpatient Clinic (Caroní Municipality, Bolívar State, Venezuela) in the Adult Hygiene Program and who requested health certification to work as food handlers were studied. Stool samples obtained by spontaneous evacuation were examined by direct microscopy and the Willis concentration method. A total of 150 individuals were infected (36.14%), 107 (25.78%) of whom with B. hominis. There was no difference between males and females (p > 0.05), but there was a significant difference between ages (chi(2) = 12.17; g.l. = 4), with infection more frequent between 18 and 27 years. In 71.02% of the cases, B. hominis was the only parasite. Giardia lamblia was the parasite most frequently associated with B. hominis (2.41%). In the majority (85%) of infected individuals, less than five microorganisms per microscopic field were observed. We conclude that B. hominis is a frequent intestinal parasite among food handlers in Caroní Municipality, Bolivar State, Venezuela.

Blastocystis hominis revisited

Blastocystis hominis is a unicellular organism found commonly in the intestinal tract of humans and many other animals. Very little is known of the basic biology of the organism, and controversy surrounds its taxonomy and pathogenicity. There morphological forms (vacuolar, granular, and ameboid) have been recognized, but recent studies have revealed several additional forms (cyst, avacuolar, and multivacuolar). The biochemistry of the organism has not been studied to any extent, and organelles and structures of unknown function and composition are present in the cells. Several life cycles have been proposed but not experimentally validated. The form used for transmission has not been defined. Infections with the organism are worldwide and appear in both immunocompetent and immunodeficient individuals. Symptoms generally attributed to B. hominis infection are nonspecific, and the need for treatment is debated. If treatment appears warranted, metronidazole is suggested as the drug of choice, although failures of this drug in eradicating the organism have been reported. Infection is diagnosed by light microscopic examination of stained smears or wet mounts of fecal material. Most laboratories identify B. hominis by observing the vacuolar form, although morphological studies indicate that other forms, such as the cyst form and multivacuolar form, also should be sought for diagnosis.

Blastocistosis y otras infecciones por protozoos intetinales en comunidades humanas ribereñas de la cuenca del rio Valdivia, Chile

Entre marzo y octubre de 1987 se examinaron muestras coprológicas de 970 personas (20, 9% de la población) pertenecientes a 209 grupos familiares de las comunidades ribereñas de la cuenca del rio Valdivia, Chile; con el propósito de determinar las prevalencias de infección por Blastocystis hominis y otros protozoos intestinales para establecer relaciones con la edad y sexo de los hospedadores, saneamiento ambiental y porcentaje de individuos infectados por grupo familiar. Un 72, 5% de las personas presentó una o más especies de protozoos intestinales. La mayor prevalencia se registró para B. hominis (61, 8%), que se incrementó con la edad del hospedador al igual que en las infecciones por Endolimax nana y Entamoeba coli. No se demostró asociación entre el sexo del hospedador y la prevalencia de infección por B. hominis y otras especies de protozoos. La prevalencia de B. hominis fue mayor en individuos que habitaban viviendas cuya disposition de excrementos era no sanitaria. Más del 60% de los integrantes de los grupos familiares presentaron infección por B. hominis en el 53, 1% de las familias encuestadas en contraposición al 2,4%-21,8% observado en infecciones por otros protozoos. El examen de 45 muestras de excrementos de cerdos, reveló infección por Blastocystis en el 22,2% de estos animales.